<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3C83A8CE-8C98-462F-BD2D-7E8E5B913716"><gtr:id>3C83A8CE-8C98-462F-BD2D-7E8E5B913716</gtr:id><gtr:name>Chirotech Technology</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3C83A8CE-8C98-462F-BD2D-7E8E5B913716"><gtr:id>3C83A8CE-8C98-462F-BD2D-7E8E5B913716</gtr:id><gtr:name>Chirotech Technology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C357C3E6-C523-4870-BED5-A0741B62A1D4"><gtr:id>C357C3E6-C523-4870-BED5-A0741B62A1D4</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Turner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FN010736%2F1"><gtr:id>C0ECF8DC-2A76-4684-8067-AE706F93F588</gtr:id><gtr:title>Novel Biocatalysts for Improved Routes to an Active Pharmaceutical Ingredient</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/N010736/1</gtr:grantReference><gtr:abstractText>The use of enzymes to catalyse reactions is a well established technique used in modern organic chemistry as the use of biological catalysts can install unique and exquisite stereochemistry and regiochemistry into a synthetic route. This project will explore the development of two enzymes that catalyse important bond forming reactions in the synthesis of an Active Pharmaceutical Ingredient and their suitability for use as industrial biocatalysts.</gtr:abstractText><gtr:technicalSummary>This project will evaluate the feasibility of replacing the current complex chemical syntheses of key intermediates towards Sofosbuvir (Sovaldi), an important drug used in the treatment of Hepatitis C, with biocatalytic steps, offering a shorter route to the product, with enhanced efficiency, economy, and environmental performance. The project will utilise the expertise of the University of Manchester in enzyme discovery and engineering to provide the new catalysts, and the manufacturing expertise of Dr. Reddy's to assess the feasibility of using these catalysts on an industrial scale.</gtr:technicalSummary><gtr:potentialImpactText>As described in the proposal submitted to IUK</gtr:potentialImpactText><gtr:fund><gtr:end>2017-01-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2016-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>93738</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chirotech Technology</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IB Catalyst Feasibility Project</gtr:description><gtr:id>0C6E8F20-B254-4194-A520-3AB6B9DC8674</gtr:id><gtr:impact>The project commenced on the 1st of February 2016 so there are no outputs yet.</gtr:impact><gtr:partnerContribution>Chirotech will help to provide training in specialised chemical synthetic methods via a series of technology transfer events.</gtr:partnerContribution><gtr:piContribution>Collaborative research project funded through the IB Catalyst scheme. We have contributed intellectual input to the project by proposing a novel route to an advanced pharmaceutical intermediate. Access to this API is a cost effective way will allow Chirotech to compete with the established production processes.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Manchester Institute of Biotechnology open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4BE487F7-0F3A-4671-A911-231C10210DD7</gtr:id><gtr:impact>The annual A-Level Open Day was run for the 5th time with the overall aim of raising the profile of biotechnology and its feeder subjects among those considering university and changing the perception of scientists among teenagers and young adults. The day was filled with lab tours, informative talks and interactive demonstrations of various aspects of the research in the institute.

We have received requests for Nuffield Summer Placements of students.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.mib.ac.uk/newsandevents/publicengagement/</gtr:url><gtr:year>2013,2014,2015,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We explored the use of an aldolase enzyme for the synthesis of sugar structures that are incorporated into drug molecules use to treat Hepatitis C. The new methodology would significantly reduce the number of steps required for the synthesis and lead to potential production cost savings that could be passed on to the consumer.</gtr:description><gtr:exploitationPathways>Future enzyme development based upon or feasibility study should facilitate the necessary technology development to fully realise the original objectives.</gtr:exploitationPathways><gtr:id>266C728D-60B1-4545-A1BB-76AF4BBF3796</gtr:id><gtr:sectors><gtr:sector>Manufacturing, including Industrial Biotechology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">BB/N010736/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>64596636-AE88-4F6E-A816-9C4C203E1197</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Catalysis &amp; surfaces</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>0B9701E7-D17F-4963-82DA-B3926A65B50A</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biological &amp; Medicinal Chem.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>35E9CECD-F211-4914-9F91-4B8FB76B773D</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Catalysis &amp; Applied Catalysis</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>DF4CD176-73D5-4039-BBC7-28D33DC364DD</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Synthetic biology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>